Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules-Reference-Cited by-同舟云学术

Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules

Published:2012-02-08 Issue:6 Volume:307 Page:
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Gossger Nicoletta,Snape Matthew D.,Yu Ly-Mee,Finn Adam,Bona Gianni,Esposito Susanna,Principi Nicola,Diez-Domingo Javier,Sokal Etienne,Becker Birgitta,Kieninger Dorothee,Prymula Roman,Dull Peter,Ypma Ellen,Toneatto Daniela,Kimura Alan,Pollard Andrew J.,European MenB Vaccine Study Group for the

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants;Archives of Disease in Childhood;2024-07-08

2. 4CMenB journey to the 10-year anniversary and beyond;Human Vaccines & Immunotherapeutics;2024-07-08

3. Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France;PharmacoEconomics - Open;2024-05-23

4. Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals;Human Vaccines & Immunotherapeutics;2024-04-02

5. Immune interface interference vaccines: An evolution‐informed approach to anti‐bacterial vaccine design;Microbial Biotechnology;2024-03